ERBB2 and breast carcinoma: The scRNA-seq data was derived from 26 breast cancer patients representing three molecular subtypes: ER+ (n = 11 patients), HER2+ (n = 5 patients) and triple-negative breast cancer (TNBC; n = 10 patients).